Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | FONSECA, Paula Fernanda Silva | |
dc.contributor.author | CANCADO, Rodolfo Delfini | |
dc.contributor.author | NAOUM, Flavio Augusto | |
dc.contributor.author | DINARDO, Carla Luana | |
dc.contributor.author | FONSECA, Guilherme Henrique Hencklain | |
dc.contributor.author | GUALANDRO, Sandra Fatima Menosi | |
dc.contributor.author | KRIEGER, Jose Eduardo | |
dc.contributor.author | PEREIRA, Alexandre Costa | |
dc.contributor.author | BRISSOT, Pierre | |
dc.contributor.author | SANTOS, Paulo Caleb Junior Lima | |
dc.date.accessioned | 2018-02-02T16:53:24Z | |
dc.date.available | 2018-02-02T16:53:24Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Background: Hereditary hemochromatosis (HH) encompasses a group of autosomal recessive disorders mainly characterized by enhanced intestinal absorption of iron and its accumulation in parenchymal organs. HH diagnosis is based on iron biochemical and magnetic resonance imaging (MRI) assessment, and genetic testing. Questionnaires, such as SF-36 (short form health survey), have been increasingly used to assess the impact of diseases on the patient's quality of life (QL). In addition, different genotypes are identified as results of genetic tests in patients with suspected primary iron overload. In the present study, our aim was to evaluate whether domains of QL are different according to genotypic groups in patients suspected of HH. Methods: Seventy-nine patients with primary iron overload were included and two genotypic groups were formed (group 1: homozygous genotype for the HFE p.Cys282Tyr mutation; group 2: other genotypes). Results: Group 1 had higher means of plasma transferrin saturation (86 +/- 19%) and serum ferritin (1669 +/- 1209 ng/mL) compared to group 2 (71 +/- 12%, 1252 +/- 750 ng/mL, respectively; p = 0.001). Four domains were significantly different among groups 1 and 2: physical functioning (p = 0.03), bodily pain (p = 0.03), vitality (p = 0.02) and social functioning (p = 0.01). Conclusions: Our main finding was that patients with p. Cys282Tyr homozygosity had a worse QL scenario assessed by SF-36, compared with patients with iron overload without the same genotype. Being aware of this relationship between genotypes and QL might be helpful in the overall management of patients suspected of hereditary hemochromatosis. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [2013/09295-3] | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2013/20614-3] | |
dc.identifier.citation | BMC MEDICAL GENETICS, v.19, article ID 3, 5p, 2018 | |
dc.identifier.doi | 10.1186/s12881-017-0513-5 | |
dc.identifier.issn | 1471-2350 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/24893 | |
dc.language.iso | eng | |
dc.publisher | BIOMED CENTRAL LTD | |
dc.relation.ispartof | BMC Medical Genetics | |
dc.rights | openAccess | |
dc.rights.holder | Copyright BIOMED CENTRAL LTD | |
dc.subject | Hereditary hemochromatosis | |
dc.subject | Quality of life | |
dc.subject | Short form health survey | |
dc.subject | SF-36 | |
dc.subject.other | primary iron overload | |
dc.subject.other | diagnosis | |
dc.subject.other | mutations | |
dc.subject.other | disease | |
dc.subject.other | sf-36 | |
dc.subject.wos | Genetics & Heredity | |
dc.title | Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | França | |
hcfmusp.affiliation.countryiso | fr | |
hcfmusp.author.external | CANCADO, Rodolfo Delfini:Santa Casa Med Sch, Hematol & Hemotherapy Sect, Sao Paulo, Brazil | |
hcfmusp.author.external | NAOUM, Flavio Augusto:Acad Ciencia & Tecnol, Sao Jose Do Rio Preto, Brazil | |
hcfmusp.author.external | BRISSOT, Pierre:Univ Rennes, Pontchaillou Univ Hosp, Liver Dis Unit, Rennes, France; Natl Reference Ctr Rare Iron Overload Dis Genet O, Rennes, France | |
hcfmusp.citation.scopus | 3 | |
hcfmusp.contributor.author-fmusphc | PAULA FERNANDA DA SILVA FONSECA | |
hcfmusp.contributor.author-fmusphc | CARLA LUANA DINARDO | |
hcfmusp.contributor.author-fmusphc | GUILHERME HENRIQUE HENCKLAIN FONSECA | |
hcfmusp.contributor.author-fmusphc | SANDRA FATIMA MENOSI GUALANDRO | |
hcfmusp.contributor.author-fmusphc | JOSE EDUARDO KRIEGER | |
hcfmusp.contributor.author-fmusphc | ALEXANDRE DA COSTA PEREIRA | |
hcfmusp.contributor.author-fmusphc | PAULO CALEB JUNIOR DE LIMA SANTOS | |
hcfmusp.description.articlenumber | 3 | |
hcfmusp.description.volume | 19 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 29301508 | |
hcfmusp.origem.scopus | 2-s2.0-85042514643 | |
hcfmusp.origem.wos | WOS:000419884300001 | |
hcfmusp.publisher.city | LONDON | |
hcfmusp.publisher.country | ENGLAND | |
hcfmusp.relation.reference | Brissot P, 2016, EXPERT REV GASTROENT, V10, P359, DOI 10.1586/17474124.2016.1119043 | |
hcfmusp.relation.reference | Campolina AG, 2008, ACTA REUMATOL PORT, V33, P127 | |
hcfmusp.relation.reference | Campolina AG, 2011, CIENC SAUDE COLETIVA, V16, P2919, DOI 10.1590/S1413-81232011000600029 | |
hcfmusp.relation.reference | Campos MO, 2008, REV BAIANA SAUDE PUB, V32, P232 | |
hcfmusp.relation.reference | Cancado R, 2015, EUR J HAEMATOL, V95, P545, DOI 10.1111/ejh.12530 | |
hcfmusp.relation.reference | Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143 | |
hcfmusp.relation.reference | de Graaff B, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0431-9 | |
hcfmusp.relation.reference | GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009 | |
hcfmusp.relation.reference | Santos PCJD, 2010, GENET TEST MOL BIOMA, V14, P803, DOI 10.1089/gtmb.2010.0056 | |
hcfmusp.relation.reference | Santos PCL, 2011, CLIN CHEM LAB MED, V49, P1633, DOI 10.1515/CCLM.2011.654 | |
hcfmusp.relation.reference | KUYKEN W, 1995, SOC SCI MED, V41, P1403 | |
hcfmusp.relation.reference | Laguardia Josué, 2013, Rev. bras. epidemiol., V16, P889, DOI 10.1590/S1415-790X2013000400009 | |
hcfmusp.relation.reference | Meiser Bettina, 2005, J Genet Couns, V14, P453, DOI 10.1007/s10897-005-6192-y | |
hcfmusp.relation.reference | Porto G, 2016, EUR J HUM GENET, V24, P479, DOI 10.1038/ejhg.2015.128 | |
hcfmusp.relation.reference | ROGERSON RJ, 1995, SOC SCI MED, V41, P1373, DOI 10.1016/0277-9536(95)00122-N | |
hcfmusp.relation.reference | Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497 | |
hcfmusp.relation.reference | Santos PCJL, 2010, BLOOD CELL MOL DIS, V45, P302, DOI 10.1016/j.bcmd.2010.08.008 | |
hcfmusp.relation.reference | Santos Paulo Caleb Júnior de Lima, 2012, Rev. Bras. Hematol. Hemoter., V34, P311, DOI 10.5581/1516-8484.20120079 | |
hcfmusp.relation.reference | Santos PC, BLOOD CELLS MOL DIS, V46, P302 | |
hcfmusp.relation.reference | Seidl E., 2004, CAD SAUDE PUBLICA, V20, P580, DOI 10.1590/S0102-311X2004000200027 | |
hcfmusp.relation.reference | Shaheen NJ, 2003, AM J GASTROENTEROL, V98, P1175, DOI 10.1016/S0002-9270(03)00109-6 | |
hcfmusp.relation.reference | Fonseca PFS, 2016, ACTA HAEMATOL-BASEL, V135, P228, DOI 10.1159/000444119 | |
hcfmusp.relation.reference | van der Plas SM, 2007, QUAL LIFE RES, V16, P375, DOI 10.1007/s11136-006-9131-y | |
hcfmusp.relation.reference | Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008 | |
hcfmusp.relation.reference | Ware JE, 1993, SF 36 HLTH SURVEY MA | |
hcfmusp.scopus.lastupdate | 2024-06-16 | |
relation.isAuthorOfPublication | 7680dbf0-41ca-4694-9ba9-2edcac6fb94f | |
relation.isAuthorOfPublication | 5ece0a6d-8843-4716-88b2-b91ff7ece503 | |
relation.isAuthorOfPublication | 4c247d4f-9b97-49f9-ae57-58a2e8b27c7c | |
relation.isAuthorOfPublication | b3f4daa9-e469-4ddd-96b8-a73732190286 | |
relation.isAuthorOfPublication | a970d450-bcd4-4662-94d6-ad1c6d043b3c | |
relation.isAuthorOfPublication | 415ce7ca-65c1-4699-b6f4-19dae8b03849 | |
relation.isAuthorOfPublication | c78fbf09-2a91-499f-862e-74830b3b5fab | |
relation.isAuthorOfPublication.latestForDiscovery | 7680dbf0-41ca-4694-9ba9-2edcac6fb94f |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_FONSECA_Quality_of_life_scores_differs_between_genotypic_groups_2018.PDF
- Tamanho:
- 365.39 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)